Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01239784
Other study ID # 1000014278
Secondary ID
Status Completed
Phase Phase 2
First received November 10, 2010
Last updated August 25, 2013
Start date October 2009
Est. completion date June 2010

Study information

Verified date August 2013
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The purpose of this project is to investigate the feasibility of using a home-based, parent-delivered model for providing neurodevelopmental rehabilitation programmes to infants who have had surgery for a complex heart defect.


Description:

Neurodevelopmental deficits are a common morbidity among children who receive surgical treatment for complex congenital heart defects in infancy. Over 40% of children with complex heart defects will have neurodevelopmental deficits that persist throughout childhood even after a successful surgical procedure in infancy1. These deficits are typically related to basic motor perceptual motor or visual motor skills. Problems integrating what is seen (visual perceptions) with body movement (motor skills) makes it difficult for children to participate in peer play and limits their ability to succeed in school, thereby having a significant impact on the child's quality of life.

Traditional, therapist-delivered rehabilitation programmes to address these delays in neurodevelopment have not previously been attempted. It would be difficult to provide direct rehabilitation programmes to these patients given that their defects are rare and few patients are located within the same geographical area. Home-based, parent-delivered rehabilitation programmes have previously been shown to be effective at improving the motor skills of school-age children with complex heart defects5. Since a home-based parent delivered model would enable the participation of infants regardless of geographic location, the feasibility of using such a model for delivering neurodevelopmental rehabilitation should be investigated.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date June 2010
Est. primary completion date June 2010
Accepts healthy volunteers No
Gender Both
Age group 12 Months to 24 Months
Eligibility Inclusion Criteria:

Families will be eligible to participate in this study if the child:

- Had the arterial switch operation (for transposition of the great arteries) or has had a Glenn procedure (for functional single ventricle).

- Is medically stable for normal infant activities.

- Is between 12 and 24 months of age in January 2010.

Exclusion Criteria:

Families will be excluded from study participation if:

- The child has a recognized syndrome or other disability affecting neurodevelopment.

- The child has had a medical procedure in the 3 months preceding the baseline study assessment.

- The cardiologist responsible for the child's care refuses to allow the child's participation.

- The child performs substantially above age-appropriate developmental milestones during the initial assessment (in which case an intervention is unlikely to have a detectable additional benefit).

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
Home-based neurodevelopmental rehabilitation programme
Participation in the study will require the parent and child to attend two assessment visits in addition to completing a series of parent and infant activities on a daily basis throughout the 10-week intervention period. The parent-led activities will include activities such as walking with the child, stacking blocks, rolling a ball to the child, hiding a toy under a blanket for the child to find, encouraging the child to kick a rattle while the child is lying on his/her back, or crawling or rolling in different directions.

Locations

Country Name City State
Canada The Hospital for Sick Children Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
The Hospital for Sick Children

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in child's neurodevelopmental status at four months using the Peabody Development Motor Scales The Peabody Development Motor Scale has demonstrated validity and reliability for children from birth to 5 years of age. Six subtests (reflexes, stationary, locomotion, object manipulation, grasping, visual-motor integration) yield gross, fine and total motor quotient scores. Baseline and four months No
Secondary Parents opinion on the home-based neurodevelopmental rehabilitation programme During the final assessment, the researcher will interview the parent to obtain their perspective on delivering the study activities at home. at 4 months No
Secondary Research students experience and perception of guiding a home-based, parent-delivered rehabilitation programme Research students participating in this project will also be interviewed regarding their experiences and perceptions of guiding a home-based, parent-delivered rehabilitation programme. at 4 months No
See also
  Status Clinical Trial Phase
Completed NCT02938429 - Physical Activity Measured Through Accelerometers and Its Association With Endothelial Function in Young Patients With Fontan Physiology N/A
Active, not recruiting NCT02110823 - Single Ventricle Reconstruction Extension Study (SVR II) - Pediatric Heart Network
Active, not recruiting NCT02455531 - Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type